Update on the corticomedullary interaction in the adrenal gland

Endocrine Development

Volumn 20, Issue , 2010, Pages 28-37

  Haase, Matthias ^a   Willenberg, Holger S ^a   Bornstein, Stefan R ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCOCORTICOID; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PRASTERONE; SULFATE;

ADRENAL CORTEX; ADRENAL INSUFFICIENCY; ARTICLE; CELL COMMUNICATION; CELL FUNCTION; CHROMAFFIN CELL; ENZYME PHOSPHORYLATION; HORMONE RECEPTOR INTERACTION; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; STEROID RELEASE; STEROIDOGENESIS;

ADRENAL CORTEX; ADRENAL GLANDS; ADRENAL MEDULLA; ADULT; ANIMALS; CELL COMMUNICATION; HUMANS; MODELS, BIOLOGICAL;

EID: 84926099509     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000321211     Document Type: Article

References (44)

1. Belgorosky A, Baquedano MS, Guercio G, Rivarola MA. Adrenarche: postnatal adrenal zonation and hormonal and metabolic regulation. Horm Res 2008;70:257-267.
2. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA: Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 1994;78:225-232.
3. Wurtman RJ, Axelrod J. Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids. Science. 1965;150:1464-1465.
4. Anderson DJ, Axel R. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids: Cell 1986;47:1079-1090.
5. Seidl K, Unsicker K. The determination of the adrenal medullary cell fate during embryogenesis: Dev Biol 1989;136:481-490.
6. Beaujean D, Rosenbaum C, Muller HW, Willemsen JJ, Lenders J, Bornstein SR: Combinatorial code of growth factors and neuropeptides define neuroendocrine differentiation in PC12 cells. Exp Neurol 2003;184:348-358.
7. Mesiano S, Jaffe RB: Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997;18:378-403. (Pubitemid 27246882)
8. Ziegler CG, Sicard F, Lattke P, Bornstein SR, Ehrhart-Bornstein M, Krug AW: Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells. Endocrinology 2008;149:320-328.
9. Krug AW, Langbein H, Ziegler CG, Bornstein SR, Eisenhofer G, Ehrhart-Bornstein M: Dehydroepiandrosterone-sulphate (DHEA-S) promotes neuroendocrine differentiation of chromaffin pheochromocytoma PC12 cells. Mol Cell Endocrinol 2009;300:126-131.
10. Charalampopoulos I, Dermitzaki E, Vardouli L, Tsatsanis C, Stournaras C, Margioris AN, Gravanis A: Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 2005;146:3309-3318.
11. Ziegler CG, Sicard F, Sperber S, Ehrhart-Bornstein M, Bornstein SR, Krug AW: DHEA reduces NGFmediated cell survival in serum-deprived PC12 cells. Ann N Y Acad Sci 2006;1073:306-311.
12. Sicard F, Krug AW, Ziegler CG, Sperber S, Ehrhart-Bornstein M, Bornstein SR: Role of DHEA and growth factors in chromaffin cell proliferation. Ann N Y Acad Sci 2006;1073:312-316.
13. Sicard F, Ehrhart-Bornstein M, Corbeil D, Sperber S, Krug AW, Ziegler CG, Rettori V, McCann SM, Bornstein SR: Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate. Proc Natl Acad Sci USA 2007;104:2007-2012.
14. Goto J, Otsuka F, Yamashita M, Suzuki J, Otani H, Takahashi H, Miyoshi T, Mimura Y, Ogura T, Makino H: Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells. Am J Physiol Endocrinol Metab 2009;296:E904-E916.
15. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP: Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998;19:101-143.
16. Willenberg HS, Schinner S, Ansurudeen I: New mechanisms to control aldosterone synthesis. Horm Metab Res 2008;40:435-441.
17. Haidan A, Bornstein SR, Glasow A, Uhlmann K, Lubke C, Ehrhart-Bornstein M: Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells. Endocrinology 1998;139:772-780.
18. Ehrhart-Bornstein M, Bornstein SR, Trzeclak WH, Usadel H, Guse-Behling H, Waterman MR, Scherbaum WA: Adrenaline stimulates cholesterol side-chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. J Endocrinol 1991;131:R5-R8.
19. Guse-Behling H, Ehrhart-Bornstein M, Bornstein SR, Waterman MR, Scherbaum WA, Adler G. Regulation of adrenal steroidogenesis by adrenaline: expression of cytochrome P450 genes: J Endocrinol 1992;135:229-237.
20. Haidan A, Bornstein SR, Liu Z, Walsh LP, Stocco DM, Ehrhart-Bornstein M: Expression of adrenocortical steroidogenic acute regulatory (StAR) protein is influenced by chromaffin cells. Mol Cell Endocrinol 2000;165:25-32.
21. Nussdorfer GG, Mazzocchi G: Vasoactive intestinal peptide (VIP) stimulates aldosterone secretion by rat adrenal glands in vivo. J Steroid Biochem 1987; 26:203-205.
22. Ehrhart-Bornstein M, Bornstein SR, Scherbaum WA, Pfeiffer EF, Holst JJ: Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology 1991;54: 623-628.
23. Bornstein SR, Haidan A, Ehrhart-Bornstein M: Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP). Endocr Res 1996;22:819-829.
24. Cobb VJ, Williams BC, Mason JI, Walker SW: Direct stimulation of cortisol secretion from the human NCI H295 adrenocortical cell line by vasoactive intestinal polypeptide. J Hypertens 1997;15:1735-1738.
25. Eskay RL, Eiden LE: Interleukin-1α and tumor necrosis factor-α differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology 1992;130:2252-2258.
26. Andreis PG, Tortorella C, Ziolkowska A, Spinazzi R, Malendowicz LK, Neri G, Nussdorfer GG: Evidence for a paracrine role of endogenous adrenomedullary galanin in the regulation of glucocorticoid secretion in the rat adrenal gland. Int J Mol Med 2007;19:511-515.
27. Ait-Ali D, Stroth N, Sen JM, Eiden LE: PACAPcytokine interactions govern adrenal neuropeptide biosynthesis after systemic administration of LPS. Neuropharmacology 2010;58:208-214.
28. Conn JW, Fajans SS: The pituitary-adrenal system. Annu Rev Physiol 1952;14:453-480.
29. Sasaki K, Aoyagi K, Murabayashi S, Baba T, Kitaoka M, Mastunaga M, Takebe K: Pituitary-adrenocortical system in patients with Shy-Drager syndrome. Horm Metab Res 1983;15:143-146.
30. Critchley JA, Henderrson CG, Moffat LE, Ungar A, Waite J, West CP: Proceedings: the release of catecholamines from perfused canine adrenal glands by corticoglucocorticoids. Journal of Physiology 1976;254:30P-31P.
31. Rudman D, Moffitt SD, Fernhoff PM, Blackston RD, Faraj BA: Epinephrine deficiency in hypocorticotropic hypopituitary children. J Clin Endocrinol Metab 1981;53:722-729.
32. Bornstein SR, Breidert M, Ehrhart-Bornstein M, Kloos B, Scherbaum WA: Plasma catecholamines in patients with Addisons disease. Clin Endocrinol (Oxf) 1995;42:215-218.
33. Zuckerman-Levin N, Tiosano D, Eisenhofer G, Bornstein S, Hochberg Z: The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab 2001;86:5920-5924.
34. Bornstein SR, Briegel J: A new role for glucocorticoids in septic shock: balancing the immune response. Am J Respir Crit Care Med 2003;167:485-486.
35. Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR: Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000;343:1362-1368.
36. Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP: Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 2002;87:3031-3037.
37. Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP: Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab 2004;89:591-597.
38. Wolf A, Willenberg HS, Cupisti K, Schott M, Geddert H, Raffel A, Bornstein SR, Scherbaum WA, Knoefel WT: Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnosic and therapeutic management. Horm Metab Res 2005;37:391-395.
39. Sakamoto N, Tojo K, Saito T, Fujimoto K, Isaka T, Tajima N, Ikeda K, Yamada H, Furuta N, Sasano H: Coexistence of aldosterone-producing adrenocortical adenoma and pheochromocytoma in an ipsilateral adrenal gland. Endocr J 2009;56:213-219.
40. Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G: Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol 2008; 158:423-429.
41. Vrezas I, Willenberg HS, Mansmann G, Hiroi N, Fritzen R, Bornstein SR: Ectopic adrenocorticotropin (ACTH) and corticotropin-releasing hormone (CRH) production in the adrenal gland: Basic and clinical aspects. Microsc Res Techniq 2003;61:308-314.
42. Willenberg HS, Feldkamp J, Lehmann R, Schott M, Goretzki PE, Scherbaum WA: A case of catecholamine-excess and Cushings syndrome due to a corticotropin-secreting paraganglioma. Ann NY Acad Sci 2006;1073:52-58.
43. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P: Propranolol therapy for ectopic betaadrenergic receptors in adrenal Cushings syndrome. N Engl J Med 1997;337:1429-1434.
44. Bornstein SR, Stratakis CA, Chrousos GP: Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 1999;130:757-765.